Login

Experience the Drillmore difference| Babak Bemani , Chief Executive Officer at Drillmore 00:10:00

Share On Facebook Share On Twitter

Babak Bemani is a CEO & Founder of Bit Azin and Drillmore Canada

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Navigating the Current Car Market: Rising Prices and Low Interest Rates | Ben Smith, Founder, Cove Financial Planning, LLC.
00:10:00
Exploring Financial Planning Administration: Roles, Qualifications, and Career Pathways
00:10:00
Nordic Gold's Path to Production: Insights from CEO Brian at the London One-to-One Conference
00:10:00
Cannasouth emphasizes science-led innovation in medicinal cannabis development | Mark Lucas, CEO, Cannasouth Ltd.
00:10:00
JAG Bhd Stock Analysis: Navigating the Recent Pullback and Future Targets
00:10:00
Palamina's Strategy: Advancing Gold and Silver Projects in Peru Amidst Market Challenges
00:10:00
Client Concerns in 2024: Portfolio Strategies and Market Trends | Hanneke Smits, CEO , The Bank of New York Mellon Corporation.
00:10:00
Helps entrepreneurs build companies to boldly transform|Lior Susan,Founding Partner,Eclipse Ventures
00:10:00
SiTime CEO Rajesh Vashist appears on CNBC's Mad Money.
00:10:00
Interview for The Success Factor on RTL7 Aired on November 27, 2016 | Marco Roeleveld - CEO of Alfen NV
00:10:00
Unveiling the Future: Alan Pangborn on Chesapeake Gold's Promising Drilling Results and Upcoming Plans
00:10:00
Invests in the brilliant people who bring ideas that matter to life|Philip Black,Co-Founder,True Ventures

© 2026 Nehu